• LAST PRICE
    5.0400
  • TODAY'S CHANGE (%)
    Trending Down-0.1300 (-2.5145%)
  • Bid / Lots
    5.0500/ 3
  • Ask / Lots
    5.0700/ 5
  • Open / Previous Close
    5.1600 / 5.1700
  • Day Range
    Low 5.0200
    High 5.2400
  • 52 Week Range
    Low 2.6800
    High 8.2212
  • Volume
    152,166
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.17
TimeVolumeCAPR
09:32 ET32515.17
09:38 ET14915.1544
09:43 ET30775.1686
09:45 ET42845.12
09:48 ET15035.12
09:50 ET20005.165
09:52 ET2005.1539
09:54 ET2005.17
09:56 ET6625.1899
09:57 ET2005.24
09:59 ET21005.2386
10:01 ET2005.2
10:03 ET1505.2326
10:06 ET2765.2
10:10 ET60195.15
10:12 ET50005.15
10:14 ET1005.12
10:24 ET22495.1
10:33 ET25005.09
10:37 ET2005.07
10:39 ET10005.0713
10:42 ET5305.075
10:44 ET9025.08
10:46 ET1005.09
10:53 ET6505.0951
10:55 ET2005.095
11:00 ET1005.11
11:06 ET7755.12
11:08 ET4005.135
11:11 ET1005.13
11:13 ET7125.11
11:26 ET5005.1
11:33 ET4005.09
11:40 ET1005.11
11:44 ET1005.09
11:51 ET1005.09
11:54 ET148175.13
11:56 ET4285.125
12:02 ET2005.115
12:09 ET3025.115
12:14 ET6825.11
12:16 ET10225.11
12:18 ET2005.11
12:23 ET2005.11
12:25 ET5235.1
12:27 ET75885.115
12:30 ET6805.105
12:38 ET5965.1
12:41 ET2005.1
12:43 ET4605.07
12:48 ET5005.08
12:52 ET1005.08
12:54 ET1005.08
12:57 ET1505.08
01:03 ET113875.1
01:06 ET10005.08
01:08 ET35615.08
01:14 ET1755.095
01:15 ET11595.095
01:17 ET5005.12
01:21 ET4005.1
01:26 ET48305.1
01:28 ET4015.12
01:30 ET10095.1
01:32 ET1005.11
01:33 ET7655.09
01:39 ET13065.09
01:42 ET2005.08
01:48 ET1005.08
01:50 ET1005.08
01:53 ET2005.08
01:55 ET121795.095
01:57 ET4005.09
02:00 ET1005.09
02:06 ET59405.06
02:08 ET14885.03
02:11 ET10605.02
02:20 ET1005.0276
02:22 ET80515.05
02:26 ET2715.04
02:27 ET1005.045
02:31 ET6335.03
02:40 ET1985.04
02:42 ET1505.02
02:44 ET1005.03
02:45 ET10005.0393
02:47 ET7245.03
02:49 ET43145.04
02:51 ET8915.04
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCAPR
Capricor Therapeutics Inc
164.5M
-5.8x
---
United StatesCLLS
Cellectis SA
150.2M
-1.1x
---
United StatesFENC
Fennec Pharmaceuticals Inc
184.7M
185.4x
---
United StatesTLSI
TriSalus Life Sciences Inc
156.7M
-2.9x
---
United StatesCRBU
Caribou Biosciences Inc
161.7M
-1.2x
---
United StatesHOWL
Werewolf Therapeutics Inc
130.8M
-2.9x
---
As of 2024-06-17

Company Information

Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy (DMD). CAP-1002 demonstrates immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. The Company leverages its exosome technology, using its StealthX platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent a diverse array of diseases.

Contact Information

Headquarters
8840 Wilshire Blvd, 2nd FloorBEVERLY HILLS, CA, United States 90211
Phone
310-358-3200
Fax
302-655-5049

Executives

Executive Chairman of the Board
Frank Litvack
President, Chief Executive Officer, Director
Linda Marban
Chief Financial Officer
Anthony Bergmann
Executive Vice President, General Counsel
Karen Krasney
Director
Paul Auwaerter

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$164.5M
Revenue (TTM)
$27.1M
Shares Outstanding
31.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
4.04
EPS
$-0.88
Book Value
$0.73
P/E Ratio
-5.8x
Price/Sales (TTM)
6.1
Price/Cash Flow (TTM)
---
Operating Margin
-96.53%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.